BPG is committed to discovery and dissemination of knowledge
Featured Articles
12/14/2023 1:38:15 PM | Browse: 339 | Download: 974
 |
Received |
|
2023-08-12 07:32 |
|
Peer-Review Started |
|
2023-08-12 07:35 |
|
First Decision by Editorial Office Director |
|
2023-09-12 16:32 |
|
Return for Revision |
|
2023-09-12 16:32 |
|
Revised |
|
2023-09-25 16:02 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2023-10-11 23:51 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2023-10-16 08:22 |
|
Articles in Press |
|
2023-10-16 08:22 |
|
Edit the Manuscript by Language Editor |
|
2023-10-23 21:12 |
|
Typeset the Manuscript |
|
2023-12-06 09:38 |
|
Publish the Manuscript Online |
|
2023-12-14 05:08 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Meta-Analysis |
| Article Title |
Prognostic value of T cell immunoglobulin and mucin-domain containing-3 expression in upper gastrointestinal tract tumors: A meta-analysis
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Jing-Jing Yan, Bing-Bing Liu, Yan Yang, Meng-Ru Liu, Han Wang, Zhen-Quan Deng and Zhi-Wei Zhang |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| the Science and Technology Research Project of Colleges and Universities of Hebei Province |
QN2020234 |
| the Precision Medicine Joint Cultivation Fund Project of Natural Science Foundation of Hebei Province |
H2021402007 |
| the Clinical Medicine Talent Cultivation Project of Health Commission of Hebei Province |
2020 |
| the Medical Science Research Project of Health Commission of Hebei Province |
20211392 |
|
| Corresponding Author |
Zhi-Wei Zhang, MD, PhD, Attending Doctor, Department of Oncology, Affiliated Hospital of Hebei University of Engineering, No. 81 Congtai Road, Congtai District, Handan 056000, Hebei Province, China. zhangzw128@126.com |
| Key Words |
Immune checkpoint; T cell immunoglobulin-3; Gastric cancer; Overall survival; Clinicopathological features |
| Core Tip |
Immune checkpoint receptor inhibitors have changed history in the long history of treating tumors, and T cell immunoglobulin and mucin-domain containing-3 (TIM3) is one of these immune checkpoint receptors. The study initially evaluated the survival-prognostic effect of TIM3 in upper gastrointestinal tumors by conducting a meta-analysis, aggregating data from several independent studies, and providing the latest comprehensive insights into the field, and further advances in immunotherapy, hoping to provide some value to future research. |
| Publish Date |
2023-12-14 05:08 |
| Citation |
Yan JJ, Liu BB, Yang Y, Liu MR, Wang H, Deng ZQ, Zhang ZW. Prognostic value of T cell immunoglobulin and mucin-domain containing-3 expression in upper gastrointestinal tract tumors: A meta-analysis. World J Gastrointest Oncol 2023; 15(12): 2212-2224
|
| URL |
https://www.wjgnet.com/1948-5204/full/v15/i12/2212.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v15.i12.2212 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
